SCNI Cash From Operations

Annual CFO

-$9.38 M
-$2.12 M-29.14%

December 31, 2023


Summary


Performance

SCNI Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSCNIcash flowmetrics:

Quarterly CFO

-$2.04 M
-$280.00 K-15.93%

September 1, 2024


Summary


Performance

SCNI Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSCNIcash flowmetrics:

TTM CFO

-$6.48 M
+$184.00 K+2.76%

September 1, 2024


Summary


Performance

SCNI TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSCNIcash flowmetrics:

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

SCNI Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-29.1%-39.3%+16.7%
3 y3 years+58.4%-243.7%+10.8%
5 y5 years+38.2%-243.7%+10.8%

SCNI Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-29.1%at low-243.7%+44.4%-486.8%+30.9%
5 y5-year-29.1%+58.4%-243.7%+44.4%-486.8%+30.9%
alltimeall time-677.0%+58.4%-661.9%+80.5%-1240.2%+60.1%

Scinai Immunotherapeutics Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
-$2.04 M(+15.9%)
-$6.48 M(-2.8%)
Jun 2024
-
-$1.76 M(+20.2%)
-$6.67 M(-14.4%)
Mar 2024
-
-$1.46 M(+19.4%)
-$7.79 M(-17.0%)
Dec 2023
-$9.38 M(+29.1%)
-$1.23 M(-44.9%)
-$9.38 M(+7.2%)
Sep 2023
-
-$2.22 M(-22.7%)
-$8.75 M(+3.8%)
Jun 2023
-
-$2.88 M(-6.0%)
-$8.43 M(-8.6%)
Mar 2023
-
-$3.06 M(+415.9%)
-$9.22 M(+26.9%)
Dec 2022
-$7.26 M(-2.2%)
-$593.00 K(-68.8%)
-$7.26 M(+8.9%)
Sep 2022
-
-$1.90 M(-48.1%)
-$6.67 M(+39.9%)
Jun 2022
-
-$3.67 M(+231.7%)
-$4.77 M(+331.7%)
Mar 2022
-
-$1.10 M(-82.1%)
-$1.10 M(-90.8%)
Dec 2021
-$7.43 M(-67.1%)
-
-
Dec 2020
-$22.56 M(+1.4%)
-
-
Dec 2019
-$22.25 M(+46.5%)
-
-
Jun 2019
-
-$6.17 M(+69.2%)
-$11.98 M(-26.3%)
Mar 2019
-
-$3.65 M(+230.7%)
-$16.25 M(+7.0%)
Dec 2018
-$15.19 M
-$1.10 M(+3.7%)
-$15.19 M(+5.8%)
Sep 2018
-
-$1.06 M(-89.8%)
-$14.35 M(-0.0%)
Jun 2018
-
-$10.44 M(+305.0%)
-$14.36 M(+198.2%)
DateAnnualQuarterlyTTM
Mar 2018
-
-$2.58 M(+858.4%)
-$4.82 M(+66.5%)
Dec 2017
-$2.89 M(+15.2%)
-$269.00 K(-74.8%)
-$2.89 M(-9.2%)
Sep 2017
-
-$1.07 M(+18.8%)
-$3.19 M(+33.6%)
Jun 2017
-
-$899.70 K(+37.5%)
-$2.38 M(+3.1%)
Mar 2017
-
-$654.40 K(+16.3%)
-$2.31 M(-7.9%)
Dec 2016
-$2.51 M(-4.6%)
-$562.50 K(+110.3%)
-$2.51 M(-7.8%)
Sep 2016
-
-$267.50 K(-67.7%)
-$2.72 M(-11.2%)
Jun 2016
-
-$827.80 K(-2.8%)
-$3.06 M(+2.6%)
Mar 2016
-
-$851.70 K(+10.0%)
-$2.99 M(+13.6%)
Dec 2015
-$2.63 M(+35.3%)
-$774.00 K(+26.8%)
-$2.63 M(+12.4%)
Sep 2015
-
-$610.50 K(-18.8%)
-$2.34 M(+7.0%)
Jun 2015
-
-$751.50 K(+52.1%)
-$2.19 M(+11.8%)
Mar 2015
-
-$494.10 K(+2.2%)
-$1.95 M(+0.5%)
Dec 2014
-$1.94 M(+61.0%)
-$483.70 K(+5.9%)
-$1.94 M(+33.1%)
Sep 2014
-
-$456.70 K(-12.2%)
-$1.46 M(+45.5%)
Jun 2014
-
-$520.40 K(+7.6%)
-$1.00 M(+107.6%)
Mar 2014
-
-$483.80 K
-$483.80 K
Dec 2013
-$1.21 M(-35.6%)
-
-
Dec 2012
-$1.88 M(-26.2%)
-
-
Dec 2011
-$2.54 M
-
-

FAQ

  • What is Scinai Immunotherapeutics annual cash flow from operations?
  • What is the all time high annual CFO for Scinai Immunotherapeutics?
  • What is Scinai Immunotherapeutics annual CFO year-on-year change?
  • What is Scinai Immunotherapeutics quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Scinai Immunotherapeutics?
  • What is Scinai Immunotherapeutics quarterly CFO year-on-year change?
  • What is Scinai Immunotherapeutics TTM cash flow from operations?
  • What is the all time high TTM CFO for Scinai Immunotherapeutics?
  • What is Scinai Immunotherapeutics TTM CFO year-on-year change?

What is Scinai Immunotherapeutics annual cash flow from operations?

The current annual CFO of SCNI is -$9.38 M

What is the all time high annual CFO for Scinai Immunotherapeutics?

Scinai Immunotherapeutics all-time high annual cash flow from operations is -$1.21 M

What is Scinai Immunotherapeutics annual CFO year-on-year change?

Over the past year, SCNI annual cash flow from operations has changed by -$2.12 M (-29.14%)

What is Scinai Immunotherapeutics quarterly cash flow from operations?

The current quarterly CFO of SCNI is -$2.04 M

What is the all time high quarterly CFO for Scinai Immunotherapeutics?

Scinai Immunotherapeutics all-time high quarterly cash flow from operations is -$267.50 K

What is Scinai Immunotherapeutics quarterly CFO year-on-year change?

Over the past year, SCNI quarterly cash flow from operations has changed by -$575.00 K (-39.30%)

What is Scinai Immunotherapeutics TTM cash flow from operations?

The current TTM CFO of SCNI is -$6.48 M

What is the all time high TTM CFO for Scinai Immunotherapeutics?

Scinai Immunotherapeutics all-time high TTM cash flow from operations is -$483.80 K

What is Scinai Immunotherapeutics TTM CFO year-on-year change?

Over the past year, SCNI TTM cash flow from operations has changed by +$1.30 M (+16.72%)